 |
News |
December, 2010 |
| GAVIS Pharmaceuticals launches first-to-market Phenelzine Sulfate 15mg Tablets, USP, therapeutic equivalent to Nardil®. |
|
July, 2010 |
| GAVIS acquires 5 Abbreviated New Drug Applications. These products will be launching in early 2011. |
| |
January, 2010 |
| GAVIS launches Mesalamine Rectal Suspension Enema, the therapeutic equivalent to Rowasa®, marking the eighth product launch in as many months. GAVIS plans to launch 8 to 10 additional products in 2010. |
| |
December, 2009 |
| GAVIS launches Orphenadrine Citrate 100mg ER Tablets, therapeutic equivalent to Norflex®. |
| |
| GAVIS announces introduction of Mesalamine Rectal Suspension Enema, the authorized generic version of Rowasa®. |
| |
November, 2009 |
| GAVIS completes acquisition of Orphenadrine Citrate 100mg ER Tablets ANDA from Actavis Totowa. |
| Read more >> |
|
| |
|
|
|
|
